Philip Rubin, Ph.D., has been named as the President and a Trustee of Rothschild Wilder, starting in January 2024. Rothschild Wilder is a private foundation, founded in 2018, that supports social justice and ethics, science and innovation, the arts and humanities, and the preservation of popular culture artifacts.

Rubin is a cognitive scientist, technologist, and science administrator who for many years has been involved with issues of science policy and ethics. Currently, he is the Chair of the Board of Directors of Haskins Laboratories in New Haven, where he is also the Chief Executive Officer emeritus and for 20 years was a senior scientist. In addition, he is a Professor Adjunct in the Dept. of Surgery, Otolaryngology, at the Yale School of Medicine, a Research Affiliate in Psychology at Yale University, a Fellow at Yale's Trumbull College, and a member of the University of Connecticut Board of Trustees where he is also Vice-Chair of the Board, leading their Research, Entrepreneurship and Innovation Committee.

From 2012 through Feb. 2015 Rubin was the Principal Assistant Director for Science at the Office of Science and Technology Policy (OSTP) in the Executive Office of the President of the United States, and led the White House's neuroscience initiative, which included the BRAIN Initiative. He is also the current Past President of the Federation of Associations in Behavioral and Brain Sciences (FABBS) in Washington, D.C.

Rubin is the grandson of Fannie (Rothschild) Auerbach.